Skip to main content
OpenTrials
Completed

NCT Number: NCT01089465

Cimex Lectularius or Bed Bugs : Vector of Infectious Agents and Pathogenic Role

During the last years, the investigators were the witness to the increase of a old emerging pest due to bed bugs (Cimex lectularius) in the world. Insecticides resistances apparitions and internationals transports increases seem to be the reasons of the pest. Cimex lectularius as vector of parasites, bacteria or virus was often suggested although not much observation are recently investigated in France. This study intends to examine the vectorial ability and the direct pathogenicity of Cimex lectularius.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Sting Bites and Stings Chemically-Induced Disorders Poisoning Wounds and Injuries

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Collection of the bedbugs and dermatological follow-up of the stings

Nice, 06000, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • On the site of takings presence of insects and eggs evoking bedbugs of beds. The identification of certainty will be made in the laboratory. All the insects not apartment to the family of Cimicidae (Criterion of exclusion) are thrown(cast) in trash cans of laboratories for organic products.
  • voluntary Patients after reading of the information sheet and the signature of the consent
  • Membership of the patient in the national insurance scheme

Exclusion criteria

  • On the site of takings absence of insects and eggs evoking bedbugs of beds
  • During the identification of certainty in the laboratory, the captured insects do not make parties of the family of Cimicidae
  • The subjects deprived of freedom.
  • Patients cancelling their consent.
  • Patients violating the protocol of search(research)

Treatment and study plan

Collection of the bedbugs and dermatological follow-up of the stings

Other

Collection of the bedbugs and dermatological follow-up of the stings at J1 J7 J14 J21 J28

Primary outcomes

  1. Morphological identification of every bedbug Porterage of bacterial agents Porterage of viral agents Biomolecular identification of the insect A breeding of bedbugs Tests of sensibility in insecticides

    Time frame: day 1

Secondary outcomes

  1. Study of the direct pathogenicity of lectularius C.

    Time frame: day 1, 7, 15 and 30

    During each of four consultations a questionnaire and a descriptive index card(form) of the general and dermatological signs will be informed. The criteria of evaluation, associated with anonimisées photos, are split into two groups: general Signs and dermatological Signs

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nice

Other

Registry information

Important dates

Study start
2010
Primary completion
2012
Study completion
2019
First posted
Mar 18, 2010
Registry last updated
Apr 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.